The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Hexam, it's genuinely painful. SCB clearly hasn't had to prepare a set of accounts in his life, thankfully.
Like I said SCB, for accounting purposes, the number of shares issued is multiplied by the share price at the date of acquisition. It doesn't matter how you try and twist it, you're wrong.
You're evidently the confused one SCB, but I'll try and help you.
As of today, tomorrow, next week, and next year - It's still the first figure.
For accounting purposes, the number of shares issued is multiplied by the share price at the date of acquisition, not whenever you feel like it suit your narrative.
Great deflection SCB, your struggle to comprehend posts is quite funny.
The maths is in my post, read it again.
Based on the shares issued, and your 650p by 2025, I stated YOUR prediction puts a £1.5bn valuation on PLT based on the 32m shares issued for 13.6%.
It's simple maths SCB, get your calculator out.
In case anyone is actually intrigued, BOO issued 32,224,662 shares to pay £107.9m towards the remaining 34% stake in PLT
£107.9m/£269.8m = ~40%
34*0.4 = 13.6%
Based on SCB's 650p by 2025 prediction, that's ~£210m for 13.6% of PLT therefore putting a valuation on PLT at circa. £1.5 BILLION
Can you see why everyone's laughing at you now SCB?
I've told you the correct answer SCB. No doubt you'll twist it and say the £107.9m in stock is not valued at that today, but my answer is correct.
Honestly, you're really embarrassing yourself, I suggest taking a good look in the mirror. Perhaps seek some professional help.
Jeremy, Hornby has a tiny free float, they only have 170m shares in issue vs BOO's 1.25bn+. This combined with their low market cap and low volume results in a greater impact on the SP.
This is absolute basics.
It has nothing to do with 'manipulation'